Brian Johnson, founder of Kernel and Blueprint longevity protocol, discusses his recent 5-MeO-DMT experience conducted as part of his systematic approach to anti-aging interventions. Johnson has spent five years implementing evidence-based longevity therapies, working through interventions from exercise and nutrition down to experimental treatments like hyperbaric oxygen and rapamycin.

The conversation covers Johnson's transition from psilocybin research to 5-MeO-DMT, his live-streamed psychedelic experience, and the neurological data he's collecting through MRI, EEG, and brain interface technology. Johnson explains how psychedelics fit into his broader longevity strategy alongside upcoming interventions like mitochondrial therapy, gene therapy, and personalized organoid testing.

5-MeO-DMT Experience: Raw Consciousness and Ego Dissolution

Johnson took 9 milligrams intramuscular plus 18 milligrams vaporized 5-MeO-DMT, which hits within 10 seconds and completely dissolves the default mode network.

"You basically experience raw consciousness and raw intelligence... if you give up, it's gonna break your brain, but if you say yes and release all attachment, it opens up unimaginable bliss" - Brian

The experience was "without question, the most dynamic experience I've ever experienced as a human" and more efficacious than diet, exercise, sleep, sauna, and hyperbaric oxygen therapy combined.

Post-experience effects include laughing in dreams (a childlike characteristic), improved relationship communication, and renewed sense of humor and excitement about daily activities.

Neuroplasticity and Default Mode Network Rewiring

The default mode network constructs self and ego through rumination patterns that become stiffer with age, making reality experience increasingly narrow.

Psychedelics scramble brain connectivity patterns like "picking up airports and repositioning them" - old neural highways quiet down while new connections emerge.

Psilocybin showed "dramatic restoration of youthful brain patterns" and moved Johnson's blood glucose from top 99.5 percentile to 99.9 percentile, indicating metabolic reset.

5-MeO-DMT "absolutely blasted clean" the default mode network compared to psilocybin's dampening effect, creating more profound neuroplasticity changes.

Psychedelics as Longevity Therapy vs Recreational Use

Johnson approached psychedelics as longevity interventions after finding preclinical mouse data on psilocybin showing reduced inflammation and anti-aging effects.

"Most people in tech world have done this in retreat centers or social environments - unquantified, unsupervised, wrong set and setting" - Brian

Risks include permanent psychosis, schizophrenic states, and dramatic life changes where people abandon careers and families after perspective shifts.

Some investors now include clauses in deal documents preventing founders from using psychedelics during company duration due to abandonment risks.

Next-Generation Longevity Interventions

Mitochondrial augmentation therapy using young family member's mitochondria is Johnson's next planned intervention, leveraging maternal mitochondrial inheritance patterns.

Johnson created organoids from his own induced pluripotent stem cells to test molecules in petri dishes before human trials, accelerating experimentation.

Foxo3 gene therapy showed over 50% tissue rejuvenation in studies - Johnson contacted the Chinese professor to explore replication and building the therapy himself.

Yamanaka factors require perfect dosing precision because "if you overdose one cell, that cell can become a cancer cell and take off as a tumor" - Brian

Societal Health Crisis and Abundance Theory

"84% of people have metabolic disorder, over 40% are obese... no wonder you have proclivity towards these outcomes" - poor health drives societal conflict - Brian

Johnson argues that abundance in health, energy, housing, and lifespan makes people happier and reduces external conflict from internal unhappiness.

GLP-1 drugs represent the "first big drop" in longevity breakthroughs, followed by plasmid-based therapies that will shift longevity from sci-fi to mainstream.

Psychedelics may provide unique psychological rejuvenation that other therapies cannot match, preventing age-related narrowing of ambition and maintaining youthful disposition.